Literature DB >> 26775215

The acetylenic tricyclic bis(cyano enone), TBE-31, targets microtubule dynamics and cell polarity in migrating cells.

Eddie Chan1, Akira Saito2, Tadashi Honda3, Gianni M Di Guglielmo4.   

Abstract

Cell migration is dependent on the microtubule network for structural support as well as for the proper delivery and positioning of polarity proteins at the leading edge of migrating cells. Identification of drugs that target cytoskeletal-dependent cell migration and protein transport in polarized migrating cells is important in understanding the cell biology of normal and tumor cells and can lead to new therapeutic targets in disease processes. Here, we show that the tricyclic compound TBE-31 directly binds to tubulin and interferes with microtubule dynamics, as assessed by end binding 1 (EB1) live cell imaging. Interestingly, this interference is independent of in vitro tubulin polymerization. Using immunofluorescence microscopy, we also observed that TBE-31 interferes with the polarity of migratory cells. The polarity proteins Rac1, IQGAP and Tiam1 were localized at the leading edge of DMSO-treated migrating cell, but were observed to be in multiple protrusions around the cell periphery of TBE-31-treated cells. Finally, we observed that TBE-31 inhibits the migration of Rat2 fibroblasts with an IC50 of 0.75 μM. Taken together, our results suggest that the inhibition of cell migration by TBE-31 may result from the improper maintenance of cell polarity of migrating cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytoskeleton; Immunofluorescence microscopy; Live cell imaging; Rac1

Mesh:

Substances:

Year:  2016        PMID: 26775215     DOI: 10.1016/j.bbamcr.2016.01.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  C151 in KEAP1 is the main cysteine sensor for the cyanoenone class of NRF2 activators, irrespective of molecular size or shape.

Authors:  Sharadha Dayalan Naidu; Aki Muramatsu; Ryota Saito; Soichiro Asami; Tadashi Honda; Tomonori Hosoya; Ken Itoh; Masayuki Yamamoto; Takafumi Suzuki; Albena T Dinkova-Kostova
Journal:  Sci Rep       Date:  2018-05-23       Impact factor: 4.379

2.  NRF2 as a Therapeutic Target in Neurodegenerative Diseases.

Authors:  Mikah S Brandes; Nora E Gray
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.